In Silico Design, Molecular Docking, Molecular Dynamics Simulation, and ADMET Evaluation of Novel Quinazoline Derivatives as EGFR Inhibitors for Non-Small-Cell Lung Cancer. AMAR [Internet]. 2026 Jun. 30 [cited 2026 Sep. 29];4(6):26-71. Available from: https://amresearchjournal.com/index.php/Journal/article/view/2371